News & Insights Search

Displaying 20 of 139 results
webimage-fda_inspections3_240125_alf.png

FDA warns HIV test distributors, supplement firm, and OTC drugmaker

Member Only
webimage-674796610.png

Developments in US trade policy affecting the dietary supplement industry

Member Only
webimage-social-media_message-bubbles_20251118.png

Influencer advertising of food supplements

Member Only
webimage-nutrition_supplements_krill_pills_20251118.png

Novel foods classification: An EU and global perspective

Member Only
webimage-class-action_lawsuit_gavel_20251118.png

Trends and developments in dietary supplement class action lawsuits in the US

Member Only
webimage-pills_capsules_blue-and-orange_20250728.png

Using AHP to guide regulatory strategy for dietary supplements

webimage-syringe_vial_250121_istock.png

Parenteral drugs: FDA replaces guidance on aluminum content limits

webimage-fda_inspections3_240125_alf.png

FDA warning letters cite STI testing failures, facilities with animal feces, and a researcher who overdosed autistic children

webimage-fda_sign2_240125_alf.png

FDA recommends participants receive key trial information early, concisely

See more
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.